July 6, 2017 | Israeli medical device company, Theranica Bio-electronics, has completed a $6 million Series A funding round led by Lightspeed Venture Partners. The funding will support the regulatory process and mass manufacturing of their wireless and electronic technologies to treat migraines. CEO Alon Ironi founded the company in 2016 with hopes of combining neuromodulation therapy with modern wireless technology.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments